More about

Interferon Alpha-2

News
December 11, 2022
3 min read
Save

Combination reduces spleen length in intermediate-, high-risk myelofibrosis

The combination of ruxolitinib and pegylated interferon alpha-2a exhibited encouraging activity among patients with myelofibrosis who had not previously received either drug, according to study results presented at ASH Annual Meeting and Exposition.

News
September 14, 2022
1 min read
Save

Topical medications for conjunctival tumors have pluses and minuses

MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.

News
January 31, 2020
5 min read
Save

Adjuvant low-dose ipilimumab extends OS vs. high-dose interferon alfa-2b in metastatic melanoma

Adjuvant ipilimumab dosed at 3 mg/kg significantly improved OS compared with high-dose interferon alfa-2b among patients with metastatic unresectable melanoma, according to results of the phase 3 E1609 trial published in Journal of Clinical Oncology.